dc.creatorMercader, Andrew Gustavo
dc.creatorDuchowicz, Pablo Román
dc.creatorFernández, Francisco Marcelo
dc.creatorCastro, Eduardo Alberto
dc.creatorBennardi, Daniel Oscar
dc.creatorAutino, Juan Carlos
dc.creatorRomanelli, Gustavo Pablo
dc.date.accessioned2020-04-15T17:28:12Z
dc.date.accessioned2022-10-14T22:56:47Z
dc.date.available2020-04-15T17:28:12Z
dc.date.available2022-10-14T22:56:47Z
dc.date.created2020-04-15T17:28:12Z
dc.date.issued2008-06
dc.identifierMercader, Andrew Gustavo; Duchowicz, Pablo Román; Fernández, Francisco Marcelo; Castro, Eduardo Alberto; Bennardi, Daniel Oscar; et al.; QSAR prediction of inhibition of aldose reductase for flavonoids; Pergamon-Elsevier Science Ltd; Bioorganic & Medicinal Chemistry; 16; 6-2008; 7470-7476
dc.identifier0968-0896
dc.identifierhttp://hdl.handle.net/11336/102644
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4316557
dc.description.abstractWe performed a predictive analysis based on quantitative structure–activity relationships (QSAR) of an important property of flavonoids, which is the inhibition (IC50) of aldose reductase (AR). The importance of AR inhibition is that it prevents cataract formation in diabetic patients. The best linear model constructed from 55 molecular structures incorporated six molecular descriptors, selected from more than a thousand geometrical, topological, quantum-mechanical, and electronic types of descriptors. As a practical application, we used the obtained QSAR model to predict the AR inhibitory effect of newly synthesized flavonoids that present 2-, 7-substitutions in the benzopyrane backbone50) of aldose reductase (AR). The importance of AR inhibition is that it prevents cataract formation in diabetic patients. The best linear model constructed from 55 molecular structures incorporated six molecular descriptors, selected from more than a thousand geometrical, topological, quantum-mechanical, and electronic types of descriptors. As a practical application, we used the obtained QSAR model to predict the AR inhibitory effect of newly synthesized flavonoids that present 2-, 7-substitutions in the benzopyrane backbone
dc.languageeng
dc.publisherPergamon-Elsevier Science Ltd
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bmc.2008.06.004
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0968089608005518
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectQSAR
dc.subjectFlavone derivative
dc.subjectAldose reductase inhibition
dc.subjectCataract prevention
dc.subjectReplacement method
dc.subjectEnhanced replacement method
dc.subjectGenetic algorithm
dc.subjectDragon molecular descriptors
dc.titleQSAR prediction of inhibition of aldose reductase for flavonoids
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución